☆ 4.7 Article

68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study

JOURNAL OF NUCLEAR MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Radiology, Nuclear Medicine & Medical Imaging

Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis

Lukas Kessler et al.

Summary: This study summarizes common findings and potential pitfalls in Ga-68-FAPI PET/CT. Common findings include uptake in degenerative lesions and head-and-neck. Pitfalls include non-tumor-specific uptake in degenerative lesions, muscle, scarring, mammary glands, or uterus.

JOURNAL OF NUCLEAR MEDICINE (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the 68Ga-FAPI PET Prospective Observational Trial

Lukas Kessler et al.

Summary: The study found that novel radiolabeled FAP inhibitors showed high tumor uptake in bone and soft-tissue sarcoma patients, indicating potential applications for clinical diagnosis and treatment.

JOURNAL OF NUCLEAR MEDICINE (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients

Justin Ferdinandus et al.

Summary: This study investigates the feasibility and safety of Y-90-FAPI-46 radioligand therapy in patients with solid tumors. The results demonstrate good tolerability and a low rate of adverse events. Furthermore, the low radiation doses to at-risk organs suggest the possibility of repeat cycles of Y-90-FAPI-46.

JOURNAL OF NUCLEAR MEDICINE (2022)

Add to Collection

Article Oncology

Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities

Wolfgang P. Fendler et al.

Summary: This study reports the efficacy and safety of 90Y-labeled FAPI-46 in patients with advanced sarcoma, pancreatic cancer, and other cancers. The results show disease control in approximately 38% of patients, with a prolonged overall survival associated with disease control. However, there were adverse events observed, with thrombocytopenia and anemia being the most common.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas

Manuel Roehrich et al.

Summary: The use of Ga-68-FAPI PET/CT imaging in PDAC patients led to significant changes in TNM staging and impacted the management of some patients.

JOURNAL OF NUCLEAR MEDICINE (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Non-malignant findings of focal 68Ga-FAPI-04 uptake in pancreas

Xiao Zhang et al.

Summary: Although Ga-68-FAPI-04 shows great potential for oncological diagnosis, focal uptake of Ga-68-FAPI-04 may occur in benign pancreatic lesions and should be carefully evaluated. Fortunately, Ga-68-FAPI-04 PET/MR, when combined with MR imaging, may potentially help avoid misdiagnosis of certain pancreatic lesions.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Equivalent tumor detection for early and late FAPI-46 PET acquisition

J. Ferdinandus et al.

Summary: The study compared early (approximately 10 min p.i.) and late (approximately 60 min p.i.) FAPI-46 imaging in patients with various types of cancer. There was equivalent lesion uptake and tumor detection between the two time points. Early FAPI-46 PET imaging was recommended for improved feasibility and scan volume in future clinical and research protocols.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Physiological FAP-activation in a postpartum woman observed in oncological FAPI-PET/CT

Katharina Dendl et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

False-Positive 68Ga-Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient With Breast Cancer

Cihan Gundogan et al.

Summary: In a patient with left lower outer quadrant breast cancer, Ga-68-FAPI-04 PET/CT showed higher accumulation in the primary tumor and axillary lymph nodes than F-18-FDG PET/CT. Despite focal increased FAPI uptake in another nodular lesion being considered malignant, the Tru-Cut biopsy revealed it as benign lymphoid tissue. This case highlights the importance of histopathological confirmation for interpreting FAPI accumulation in breast tissue.

CLINICAL NUCLEAR MEDICINE (2021)

Add to Collection

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Increased 68Ga-FAPI-04 Uptake in Schmorl Node in a Patient With Gastric Cancer

Rong Lin et al.

Summary: A 78-year-old man diagnosed with gastric adenocarcinoma underwent F-18-FDG and Ga-68-FAPI-04 PET/CT scans, which showed intense radioactivity in the gastric cancer and increased uptake in the benign Schmorl node. Two months after radical gastrectomy, a follow-up CT revealed no change in the Schmorl node in the T5 vertebrae.

CLINICAL NUCLEAR MEDICINE (2021)

Add to Collection

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Elevated 68Ga-FAPI Activity in Splenic Hemangioma and Pneumonia

Huipan Liu et al.

Summary: Our case illustrates that splenic hemangioma can also reveal increased FAPI activity, which is not evident on FDG PET/CT scans.

CLINICAL NUCLEAR MEDICINE (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients

Frederik L. Giesel et al.

Summary: The study aimed to compare Ga-68-FAPI and F-18-FDG in organ biodistribution and tumor uptake in PET/CT, showing that Ga-68-FAPI has lower uptake in most normal tissues compared to F-18-FDG, resulting in significantly higher TBRs at some sites for Ga-68-FAPI.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-FAPI-PET/CT in patients with various gynecological malignancies

Katharina Dendl et al.

Summary: Ga-68-FAPI-PET/CT demonstrates high tracer uptake for staging and follow-up of gynecological tumors, with sharp contrasts in primary and metastatic lesions and higher TBRs than F-18-FDG-PET/CT. The presence or absence of the menstrual cycle seems to correlate with FAPI accumulation in the normal endometrium and breast.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers

M. Syed et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers

Frederik L. Giesel et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention

Anastasia Loktev et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

Clemens Kratochwil et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein

Thomas Lindner et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Ga-68-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET Imaging

Christoph Rischpler et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics

Ellen Pure et al.

ONCOGENE (2018)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients

Wolfgang Peter Fendler et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-PSMA-11PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study

Wolfgang Peter Fendler et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Add to Collection

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Consensus Interpretation in Imaging Research: Is There a Better Way?

Alexander A. Bankier et al.

RADIOLOGY (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.